Summary
- Current Price
- As of today, OCUL price is $8.88, down -1.99% on
- Current Price All-Time High
- OCUL price is currently -79.90% below its historical high of $44.19 set on
- Market Cap
- OCUL current market cap is $2B, up +60.33% over the past 365 days
- PE Ratio
- OCUL PE ratio is unknown
- Revenue
- OCUL current annual revenue is $51.95M, down -18.47% year-over-year
- Next Earnings
- The next earnings release for OCUL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Ocular Therapeutix, Inc. |
| Ticker | NASDAQ: OCUL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ocutx.com |
| Employees | 274 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $8.88 | |
| Price, 1D Change | -1.99% | |
| $2B | ||
| - | ||
| - | ||
| 1.16 | ||
| $52M | ||
| Revenue, 1Y Change | -18.47% | |
| -$1.42 | ||
| EPS, 1Y Change | -16.16% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.42 | ||
| EPS Estimate | N/A | -$1.32 |
| EPS Est. Change | N/A | +7.41% |
| $51.95M | ||
| Revenue Estimate | N/A | $59.80M |
| Revenue Est. Change | N/A | +15.10% |
| Current Price | $8.88 | |
| Price Target | - | $26.00 |
| Price Tgt. Change | - | +192.79% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.07 | -$1.22 | -14.62% | |
| -$1.43 | -$1.42 | +0.45% | |
| -$1.30 | N/A | +8.24% | |
| -$1.25 | N/A | +12.17% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $63.77M | $63.72M | -0.08% | |
| $54.83M | $51.95M | -5.25% | |
| $57.17M | N/A | +10.06% | |
| $120.69M | N/A | +132.31% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $8.88 | |
| $10.96 | ||
| SMA 200 vs Price | +23.41% | |
| $11.55 | ||
| SMA 50 vs Price | +30.02% | |
| 1.16 | ||
| $0.68 | ||
| 34.95 | ||
| 55.01% | ||
| 69.49% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $51.95M | ||
| -$1.42 | ||
| $45.38M | ||
| 87.35% | ||
| -$270.02M | ||
| -519.75% | ||
| -$265.94M | ||
| -511.90% | ||
| -$265.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 15.39 | ||
| 15.32 | ||
| - | ||
| 2 | ||
| 5.29 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 36.42 | ||
| 2.89 | ||
| -4.64 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $654.31M | ||
| $737.06M | ||
| $811.14M | ||
| $782.13M | ||
| $156.83M | ||
| $50.81M | ||
| $76.97M | ||
| $2.82M | ||
| $4.15M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $317.89M | ||
| $315.39M | ||
| $6.57M | ||
| $0.00 | ||
| $4.32M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$204.88M | ||
| -$11.88M | ||
| $561.72M | ||
| $12.01M | ||
| -$216.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Baird | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with OCUL
FAQ
What is the ticker symbol for Ocular Therapeutix, Inc.?
The ticker symbol for Ocular Therapeutix, Inc. is NASDAQ:OCUL
Does Ocular Therapeutix, Inc. pay dividends?
No, Ocular Therapeutix, Inc. does not pay dividends
What sector is Ocular Therapeutix, Inc. in?
Ocular Therapeutix, Inc. is in the Healthcare sector
What industry is Ocular Therapeutix, Inc. in?
Ocular Therapeutix, Inc. is in the Biotechnology industry
What country is Ocular Therapeutix, Inc. based in?
Ocular Therapeutix, Inc. is headquartered in United States
When did Ocular Therapeutix, Inc. go public?
Ocular Therapeutix, Inc. initial public offering (IPO) was on July 25, 2014
Is Ocular Therapeutix, Inc. in the S&P 500?
No, Ocular Therapeutix, Inc. is not included in the S&P 500 index
Is Ocular Therapeutix, Inc. in the NASDAQ 100?
No, Ocular Therapeutix, Inc. is not included in the NASDAQ 100 index
Is Ocular Therapeutix, Inc. in the Dow Jones?
No, Ocular Therapeutix, Inc. is not included in the Dow Jones index
When was Ocular Therapeutix, Inc. last earnings report?
Ocular Therapeutix, Inc.'s most recent earnings report was on February 5, 2026
When does Ocular Therapeutix, Inc. report earnings?
The next expected earnings date for Ocular Therapeutix, Inc. is May 5, 2026
Data Sources & References
- OCUL Official Website www.ocutx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1393434/000110465926010664/0001104659-26-010664-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1393434/000110465926010664/0001104659-26-010664-index.htm
- OCUL Profile on Yahoo Finance finance.yahoo.com/quote/OCUL
- OCUL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ocul